covid
Buscar en
Revista Colombiana de Cardiología
Toda la web
Inicio Revista Colombiana de Cardiología Consideraciones nutricionales en el paciente con falla cardíaca crónica
Información de la revista
Vol. 19. Núm. 6.
Páginas 312-319 (noviembre - diciembre 2012)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 19. Núm. 6.
Páginas 312-319 (noviembre - diciembre 2012)
Open Access
Consideraciones nutricionales en el paciente con falla cardíaca crónica
Nutritional considerations in patients with chronic heart failure
Visitas
15576
Mario A. Hernández1,2,*, Aldo F. Patiño1,2
1 Fundación Santa Fe de Bogotá. Bogotá, Colombia
2 Universidad El Bosque. Bogotá, Colombia
Este artículo ha recibido

Under a Creative Commons license
Información del artículo

La insuficiencia cardíaca congestiva es un síndrome caracterizado por reducción del gasto cardíaco, aumento de las presiones de llenado ventricular y activación neuroendocrina, que lleva a un proceso de fibrosis y apoptosis de la célula cardíaca. Afecta alrededor de 23 millones de personas en el mundo y confiere un pésimo pronóstico una vez se diagnostica. Desde el punto de vista fisiopatológico, la relación entre citocinas pro-inflamatorias, activación neuro-hormonal y alteraciones gastrointestinales conduce a un estado denominado caquexia cardíaca, determinado por pérdida acelerada de peso, fatiga, reducción de la fuerza muscular, anorexia y disminución de la calidad de vida; este proceso es capaz de deteriorar aún más el pronóstico vital de estos pacientes. En las últimas dos décadas, se han realizado avances en el tratamiento farmacológico y eléctrico de la falla cardíaca; sin embargo los estudios en el campo no farmacológico son pocos, en especial en el aspecto nutricional, y así mismo son escasas las recomendaciones de las guías internacionales acerca del tema. En estudios pequeños, una aproximación nutricional ha demostrado impactar de manera positiva la calidad de vida y tolerancia al ejercicio, si bien se requieren grandes estudios para determinar la viabilidad de este abordaje en pacientes con falla cardíaca.

Palabras clave:
insuficiencia cardiaca crónica
metabolismo
nutrición

Congestive heart failure is a syndrome characterized by reduced cardiac output, increased ventricular filling pressures and neuroendocrine activation, which leads to a process of cardiac cell fibrosis and apoptosis. It affects nearly 23 million people worldwide and once diagnosed has a poor prognosis. From a physiopathological point of view, the relationship between pro-inflammatory cytokines, neurohormonal activation and gastrointestinal disturbances leads to a condition called cardiac cachexia, characterized by accelerated weight loss, fatigue, decreased muscle strength, anorexia and decreased quality of life. This process can further deteriorate life prognosis of these patients. In the past two decades many advances regarding the pharmacological and electrical treatment of heart failure have been made, but studies in the non-pharmacological field are few, especially in the nutritional aspect, and likewise, the recommendations of the international guidelines on the subject are scarce. In small studies, a nutritional approach has shown to positively impact the quality of life and exercise tolerance, although larger studies are needed to determine the feasibility of this approach in patients with heart failure.

Keywords:
chronic heart failure
metabolism
nutrition
El Texto completo está disponible en PDF
Bibliografía
[1.]
E.A. Gómez, J.M. Senior, S. Vélez, et al.
Guías colombianas sobre la evaluación y el manejo de la falla cardíaca crónica en el adulto.
Rev Cardiol Col, 14 (2007), pp. 13-50
[2.]
A.L. Bui, T.B. Horwich, G.C. Fonarow.
Epidemiology and risk profile of heart failure.
Nat Rec Cardiol, 8 (2011), pp. 30-41
[3.]
G.S. Bleumink, A.M. Knetsch, M.C. Sturkenboom, et al.
Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study.
Eur Heart J, 25 (2004), pp. 1614-1619
[4.]
S. Haehling, R. Stepney, S.D. Anker.
Advances in understanding and treating cardiac cachexia: highlights from the 5th cachexia conference.
Int J Cardiol, 144 (2010), pp. 347-349
[5.]
S.D. Anker, P. Ponikowski, S. Varney, et al.
Wasting as independent risk factor for mortality in chronic heart failure.
Lancet, 349 (1997), pp. 1050-1053
[6.]
S.C. Lemon, B. Olendski, R. Magner, et al.
The dietary quality of persons with heart failure in NHANES 1999-2006.
J Gen Intern Med, 25 (2009), pp. 135-140
[7.]
W.J. Evans, J.E. Morley, J. Argilés, et al.
Cachexia: a new definition.
Clin Nutr, 27 (2008), pp. 793-799
[8.]
L.M. Freeman.
The pathophysiology of cardiac cachexia.
Curr Opin Support Palliate Care, 3 (2009), pp. 276-281
[9.]
V.M. Christensen, T. Omland.
Multiple cytokine biomarkers in heart failure.
Expert Rev Mol Diagn, 10 (2010), pp. 147-157
[10.]
S. Von Haehling, W. Doehner, S.D. Anker.
Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure.
Cardiovascular Research, 73 (2007), pp. 298-309
[11.]
S.D. Anker, T.P. Chua, P. Ponikowski, D. Harrington, et al.
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.
Circulation, 96 (1997), pp. 526-534
[12.]
N. Nagaya, M. Uematsu, M. Kojima, et al.
Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors.
Circulation, 104 (2001), pp. 2034-2038
[13.]
A. Sandek, J. Bauditz, A. Swidsinski, et al.
Altered intestinal function in patients with chronic heart failure.
J Am Coll Cardiol, 50 (2007), pp. 1561-1569
[14.]
A. Sandek, W. Doehner, S.D. Anker, et al.
Nutrition in heart failure: an update.
Curr Opin Clin Nutr Metab Care, 12 (2009), pp. 384-391
[15.]
V. Ralevic.
splanchnic circulatory physiology.
Hepatogastroenterology, 46 (1999), pp. 1409-1413
[16.]
T. Celik, A. Lyisoy, U.C. Yuksel, et al.
The small intestine: a critical linkage in pathophysiology of cardiac cachexia.
Int J Cardiol, 143 (2010), pp. 200-216
[17.]
A.K. Yamauti, M.E. Ochiai, P.S. Bifulco, et al.
Subjective global assessment of nutritional status in cardiac patients.
Arq Bras Cardiol, 87 (2006), pp. 707-712
[18.]
J.P. Araújo, P. Laurenco, F. Rocha- Gonzalez, et al.
Nutritional markers and prognosis in cardiac cachexia.
Int J Cardiol, 146 (2011), pp. 359-363
[19.]
J. Springer, G. Filippatos, Y.J. Akashi, et al.
Prognosis and therapy approaches of cardiac cachexia.
Curr Opin Cardiol, 21 (2006), pp. 229-233
[20.]
G. Azhar, J.Y. Wei.
Nutrition and cardiac cachexia.
Curr Opin Clin Nutr Metab Care, 9 (2006), pp. 18-23
[21.]
M. Piepoli, M. Flather, A.J.S. Coats.
Overview of studies of exercise training in chronic heart failure: the need for a prospective randomized multicentre European trial.
Eur Heart J, 19 (1998), pp. 830-841
[22.]
K. Discktein, A. Cohen-solal, G. Filippatos, et al.
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008.
Eur Heart J, 29 (2008), pp. 2388-2442
[23.]
A.M. Feldman, G.S. Francis, T.G. Ganiats, et al.
2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults.
Circulation, 119 (2009), pp. 1977-2016
[24.]
S.D. Anker, M. Jhon, P.U. Pedersen, et al.
ESPEN guideline on enteral nutrition: cardiology and pulmonology.
Clinical Nutrition, 25 (2006), pp. 311-318
[25.]
S.D. Anker, A. Laviano, G. Filippatos, et al.
ESPEN guideline on parenteral nutrition: cardiology and pneumology.
Clinical Nutrition, 28 (2009), pp. 455-460
[26.]
M.N. Rujinski.
Nutrición en la insuficiencia cardíaca un gran eslabón.
Rev Insuf Card, 2 (2007), pp. 115-117
[27.]
V. Sahade.
Nutritional treatment for heart failure patients.
Rev Nutr Campinas, 22 (2009), pp. 399-408
[28.]
W.C. Stanley, E.R. Dabkowski, R.F. Ribeiro, K.A. O’Connell.
Dietary fat and heart failure: moving from lipotoxicity to lipoprotection.
Circ Res, 110 (2012), pp. 764-776
[29.]
K. Yamagishi, H. Iso, Date Ch, et al.
Fish Ω-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort Japanese men and women.
J Am Coll Cardiol, 52 (2008), pp. 988-996
[30.]
K.K. Witte, A.L. Clark, J.G. Cleland.
Chronic heart failure and micronutrients.
J Am Coll Cardiol, 37 (2001), pp. 1765-1774
[31.]
M. De Lorgeril, P. Salen, M. Accominotti, et al.
Dietary and blood antioxidants in patients with chronic heart failure.
Insights into the potential importance of selenium in heart failure. Eur J Heart Fail, 3 (2001), pp. 661-669
[32.]
K.K. Witte, N.P. Nikitin, A.C. Parker, et al.
The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure.
Eur heart J, 26 (2005), pp. 2238-2244
[33.]
M. De Lorgeril, P. Salen, P. Defaye.
Importance of nutrition in chronic heart failure patients.
Eur heart J, 26 (2005), pp. 2215-2217
[34.]
K.K. Witte, A.L. Clark.
Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives.
Heart Fail Rev, 11 (2006), pp. 65-74
[35.]
S.S. Schleithoff, A. Zittermann, G. Tenderich, D. Vitamin, et al.
supplementation improves cytokine profiles in patients with heart failure: a double-blind, randomized, placebo-controlled trial.
Am J Clin Nutr, 83 (2006), pp. 754-759
[36.]
D. ALmoznino-sarafian, G. Sarafian, F. Berman, et al.
Magnesium administration may improve heart rate variability in patients with heart failure.
Nutr Metab Card Dis, 19 (2009), pp. 641-645
Copyright © 2012. Sociedad Colombiana de Cardiología y Cirugía Cardiovascular
Opciones de artículo